Eracal Therapeutics Ltd. develops first-in-class drugs to treat obesity and its comorbidities.
Location: Switzerland, Zurich, Schlieren
Total raised: $256.92M
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.01.2024 | - | $255.91M | - |
| 04.06.2019 | - | $1.01M | - |
Mentions in press and media 16
Show more